1. Home
  2. PSTL vs CCCC Comparison

PSTL vs CCCC Comparison

Compare PSTL & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Postal Realty Trust Inc.

PSTL

Postal Realty Trust Inc.

HOLD

Current Price

$23.64

Market Cap

688.8M

Sector

Real Estate

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.39

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSTL
CCCC
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.8M
404.7M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
PSTL
CCCC
Price
$23.64
$3.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$20.19
$12.20
AVG Volume (30 Days)
319.6K
1.8M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
4.62%
N/A
EPS Growth
123.81
16.45
EPS
0.26
N/A
Revenue
$95,823,000.00
$35,947,000.00
Revenue This Year
$18.01
N/A
Revenue Next Year
$11.38
N/A
P/E Ratio
$93.35
N/A
Revenue Growth
25.47
1.02
52 Week Low
$14.25
$1.69
52 Week High
$25.22
$5.17

Technical Indicators

Market Signals
Indicator
PSTL
CCCC
Relative Strength Index (RSI) 56.56 37.75
Support Level $23.63 $3.38
Resistance Level $24.57 $3.91
Average True Range (ATR) 0.55 0.17
MACD 0.06 -0.04
Stochastic Oscillator 61.54 13.82

Price Performance

Historical Comparison
PSTL
CCCC

About PSTL Postal Realty Trust Inc.

Postal Realty Trust Inc is an internally managed real estate investment trust. It is engaged in acquiring and managing properties mainly leased to the United States Postal Service, or the USPS, ranging from last-mile post offices to industrial facilities. The Trust's objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of its revenue is generated in the form of rental income.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: